Share on StockTwits

Tenet Healthcare Corp (NYSE:THC) CEO Trevor Fetter sold 33,642 shares of Tenet Healthcare Corp stock on the open market in a transaction that occurred on Monday, August 18th. The shares were sold at an average price of $60.01, for a total transaction of $2,018,856.42. Following the completion of the transaction, the chief executive officer now directly owns 818,432 shares of the company’s stock, valued at approximately $49,114,104. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Tenet Healthcare Corp (NYSE:THC) traded up 0.47% on Friday, hitting $60.345. The stock had a trading volume of 165,174 shares. Tenet Healthcare Corp has a 52-week low of $36.87 and a 52-week high of $60.62. The stock has a 50-day moving average of $52. and a 200-day moving average of $46.47. The company’s market cap is $5.909 billion.

Tenet Healthcare Corp (NYSE:THC) last announced its earnings results on Monday, August 4th. The company reported ($0.27) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.01 by $0.28. The company had revenue of $4.04 billion for the quarter, compared to the consensus estimate of $3.94 billion. During the same quarter in the previous year, the company posted $0.66 earnings per share. The company’s revenue for the quarter was up 66.9% on a year-over-year basis. On average, analysts predict that Tenet Healthcare Corp will post $1.39 earnings per share for the current fiscal year.

Several analysts have recently commented on the stock. Analysts at RBC Capital raised their price target on shares of Tenet Healthcare Corp from $43.00 to $62.00 in a research note on Thursday, August 14th. They now have a “sector perform” rating on the stock. Separately, analysts at Citigroup Inc. reiterated a “buy” rating on shares of Tenet Healthcare Corp in a research note on Wednesday, August 6th. They now have a $66.00 price target on the stock, up previously from $52.00. Finally, analysts at Credit Suisse reiterated a “neutral” rating on shares of Tenet Healthcare Corp in a research note on Wednesday, August 6th. They now have a $63.00 price target on the stock, up previously from $51.00. Ten equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Tenet Healthcare Corp currently has an average rating of “Hold” and a consensus price target of $63.46.

Tenet Healthcare Corporation (NYSE:THC) along with its subsidiaries, is an investor-owned health care services company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.